Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation-Reference-Cited by-同舟云学术

Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation

Published:2011-02-11 Issue:3 Volume:53 Page:821-832
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Orellana-Gavaldà Josep M.,Herrero Laura,Malandrino Maria Ida,Pañeda Astrid,Sol Rodríguez-Peña Maria,Petry Harald,Asins Guillermina,Van Deventer Sander,Hegardt Fausto G.,Serra Dolors

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24140/fullpdf

Reference37 articles.

1. Disordered lipid metabolism and the pathogenesis of insulin resistance;Savage;Physiol Rev,2007

2. Obesity, inflammation, and insulin resistance;Shoelson;Gastroenterology,2007

3. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels;Stefanovic-Racic;Am J Physiol Endocrinol Metab,2008

4. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance;An;Nat Med,2004

5. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2;Savage;J Clin Invest,2006

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium butyrate alleviates fructose-induced non-alcoholic fatty liver disease by remodeling gut microbiota to promote γ-amino butyric acid production;Food Science and Human Wellness;2024-03

2. Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1;Phytomedicine;2024-01

3. Dietary Achievable Dose of Protocatechuic Acid, a Metabolite of Flavonoids, Inhibits High‐Fat Diet‐Induced Obesity in Mice;Molecular Nutrition & Food Research;2023-11-23

4. The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach;Current Issues in Molecular Biology;2023-11-14

5. Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases;Biotechnology and Bioengineering;2023-10-26